Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Ikapharmindo Putramas Tbk. (IKPM) vs Reksa Dana Syariah Mandiri ETF Emas (XMES) Price & Performance

Ikapharmindo Putramas Tbk.Trade
Reksa Dana Syariah Mandiri ETF EmasTrade

Price performance (Past 24H)

Key statistics

Ikapharmindo Putramas Tbk. vs Reksa Dana Syariah Mandiri ETF Emas — how do they compare? Ikapharmindo Putramas Tbk. trades at Rp183 (market cap 313.35B, 1.41M 24h volume), while Reksa Dana Syariah Mandiri ETF Emas trades at Rp793 (market cap 13.37B, 335.6K 24h volume). The key difference: Ikapharmindo Putramas Tbk. is far larger — about 23.4× Reksa Dana Syariah Mandiri ETF Emas's market cap, and Ikapharmindo Putramas Tbk. is more actively traded (1.41M versus 335.6K). Which is the better fit depends on your goals.

IKPMXMES
Market Cap
313.35B13.37B
Volume
1.41M335.6K
Lot
14.1K3.36K
Turnover
271.25M265.66M
Average Price
192.33791.59
Value
271.25M265.66M
Indicative Equilibrium Price
186793
Indicative Equilibrium Volume
60038

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

IKPM
View details

About Ikapharmindo Putramas Tbk.

PT Ikapharmindo Putramas Tbk (the “Company") was established under the name of PT Ikapharm Indonesia based on Notarial Deed of Lien Tanudirdja, S.H., No. 63 dated May 18, 1978. The Company started its commercial operations in 1978. PT Ikapharma Inti Mas is the Parent Company of the Company.

Read more on IKPM

About Reksa Dana Syariah Mandiri ETF Emas

Read more on XMES